granisetron has been researched along with Mouth Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, M; Shikimori, M; Yamshita, Y | 1 |
Hashimoto, K; Komatsu, H; Shikimori, M; Yamashita, Y | 1 |
Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T | 1 |
2 trial(s) available for granisetron and Mouth Neoplasms
Article | Year |
---|---|
[Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Stomatitis | 2005 |
[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
Topics: Adult; Aged; Anorexia; Cisplatin; Domperidone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mouth Neoplasms; Nausea; Vomiting | 1993 |
1 other study(ies) available for granisetron and Mouth Neoplasms
Article | Year |
---|---|
Granisetron reduces clinical and histological response to intra-arterial neoadjuvant chemotherapy in oral squamous cell carcinoma.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Cohort Studies; Doxorubicin; Drug Interactions; Female; Granisetron; Humans; Injections, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Peplomycin; Retrospective Studies | 2006 |